All questions
Question 1
In a specialty sterile compounding facility, what type of documentation is required to verify aseptic competency?
- A résumé listing sterile compounding duties, kept on file without competency testing results
- A log of controlled substance inventories signed monthly by a pharmacist
- Completed media-fill and gloved fingertip sampling records linked to the individual and dates (correct answer)
- A state license copy for the facility posted in the cleanroom anteroom
Explanation: This question tests understanding of pharmacy law regarding competency training for compounding personnel (Domain 1: Pharmacy and Pharmacist Practice). Competency training ensures personnel can safely and effectively compound medications, following USP standards which require specific training and documentation. The scenario provided illustrates how a pharmacy implements these requirements, including regular assessments and detailed record-keeping in a sterile compounding facility. The correct answer is justified by its alignment with USP guidelines, ensuring personnel maintain necessary skills via media-fill and gloved fingertip sampling records. A common distractor fails by suggesting outdated practices no longer accepted by regulatory bodies, highlighting the importance of current knowledge, such as relying on résumés without testing. To teach this concept, emphasize the difference between sterile and non-sterile compounding requirements, and reinforce the need for ongoing education to stay compliant with evolving standards.
Question 2
In hospital sterile compounding, which module best addresses contamination control as part of competency training?
- General occupational safety training without cleanroom-specific procedures or observation
- Telephone etiquette and de-escalation training for patient complaints at the pharmacy window
- Inventory ordering and wholesaler account management training for procurement staff
- Hand hygiene, garbing, disinfecting, and airflow awareness with documented practical evaluation (correct answer)
Explanation: This question tests understanding of pharmacy law regarding competency training for compounding personnel (Domain 1: Pharmacy and Pharmacist Practice). Competency training ensures personnel can safely and effectively compound medications, following USP standards which require specific training and documentation. The scenario provided illustrates how a pharmacy implements these requirements, including regular assessments and detailed record-keeping in hospital sterile compounding. The correct answer is justified by its alignment with USP guidelines, ensuring personnel maintain necessary skills in contamination control through hygiene and garbing evaluations. A common distractor fails by suggesting outdated practices no longer accepted by regulatory bodies, highlighting the importance of current knowledge, such as focusing on telephone etiquette. To teach this concept, emphasize the difference between sterile and non-sterile compounding requirements, and reinforce the need for ongoing education to stay compliant with evolving standards.
Question 3
During new hire orientation for sterile compounding, which practice best supports USP <797> competency verification?
- Allow independent compounding after reading policies, with no direct observation of technique
- Permit compounding if the technician completes HIPAA training and annual fire safety modules
- Require simulated aseptic manipulations, followed by documented observation and testing before independent work (correct answer)
- Delay all training until the technician has worked ninety days in the department
Explanation: This question tests understanding of pharmacy law regarding competency training for compounding personnel (Domain 1: Pharmacy and Pharmacist Practice). Competency training ensures personnel can safely and effectively compound medications, following USP standards which require specific training and documentation. The scenario provided illustrates how a pharmacy implements these requirements, including regular assessments and detailed record-keeping during new hire orientation for sterile compounding. The correct answer is justified by its alignment with USP <797> guidelines, ensuring personnel maintain necessary skills through simulated manipulations and testing. A common distractor fails by suggesting outdated practices no longer accepted by regulatory bodies, highlighting the importance of current knowledge, such as allowing independent work without observation. To teach this concept, emphasize the difference between sterile and non-sterile compounding requirements, and reinforce the need for ongoing education to stay compliant with evolving standards.
Question 4
According to USP <795> training expectations, what documentation best verifies nonsterile compounding competency for personnel?
- A copy of the pharmacy's mission statement kept in the quality assurance binder
- A single email stating the technician has prior compounding experience at another pharmacy
- A verbal confirmation entered by the technician without supervisor review or dates
- Signed training record showing instruction, observed technique, and assessment results for assigned tasks (correct answer)
Explanation: This question tests understanding of pharmacy law regarding competency training for compounding personnel (Domain 1: Pharmacy and Pharmacist Practice). Competency training ensures personnel can safely and effectively compound medications, following USP standards which require specific training and documentation. The scenario provided illustrates how a pharmacy implements these requirements, including regular assessments and detailed record-keeping for nonsterile compounding under USP <795>. The correct answer is justified by its alignment with USP guidelines, ensuring personnel maintain necessary skills through signed training records with observed techniques. A common distractor fails by suggesting outdated practices no longer accepted by regulatory bodies, highlighting the importance of current knowledge, such as using verbal confirmations without review. To teach this concept, emphasize the difference between sterile and non-sterile compounding requirements, and reinforce the need for ongoing education to stay compliant with evolving standards.
Question 5
A pharmacy technician is newly hired and will be responsible for preparing non-hazardous sterile preparations in the IV cleanroom.
According to USP standards, which of the following must this technician successfully complete before being permitted to compound sterile preparations for patient use?
- A written exam on aseptic technique and a media-fill test within the first 90 days of employment.
- Three sets of gloved fingertip and thumb samples with zero colony-forming units (CFUs) following initial garbing competency evaluation. (correct answer)
- One set of gloved fingertip and thumb samples with fewer than 3 CFUs and observation by the designated person for one week.
- A didactic training program on sterile compounding and a certificate of completion from an accredited provider.
Explanation: USP <797> requires that before an individual can begin to compound sterile preparations, they must successfully complete initial training, which includes passing three sets of gloved fingertip and thumb sampling (for both hands) with a result of zero CFUs. This is performed after the initial garbing and gloving competency assessment. The other options describe incomplete or incorrectly timed requirements.
Question 6
An experienced pharmacy technician performs their semi-annual gloved fingertip and thumb sampling (GFS). The results from the laboratory indicate a total of 4 colony-forming units (CFUs) grew on one of the plates.
What is the most appropriate immediate action for the pharmacy's designated person to take?
- Allow the technician to continue compounding but require them to wear double gloves for all future preparations.
- Document the failure and have the technician perform three consecutive successful GFS tests at their next scheduled assessment.
- Prohibit the technician from compounding sterile preparations and require retraining and reassessment of their garbing and aseptic technique. (correct answer)
- Discard the result as a likely anomaly and have the technician perform another GFS test immediately without any additional training.
Explanation: A GFS result of greater than 3 CFUs (for Category 1 or 2 CSPs) constitutes a failure. The required corrective action is to immediately prohibit the individual from compounding sterile preparations. They must then undergo retraining in garbing and aseptic technique, followed by a successful reassessment before they can be requalified to compound.
Question 7
A pharmacist is being trained to compound chemotherapy infusions in a hospital's oncology satellite pharmacy. This pharmacist has prior experience in non-hazardous sterile compounding.
According to USP <800>, what specific training and competency assessment is required before this pharmacist can handle hazardous drugs (HDs)?
- Certification in oncology pharmacy practice from the Board of Pharmacy Specialties (BPS).
- Completion of a media-fill test using a benign, colored solution to simulate an HD.
- A review of the pharmacy's dispensing error rates for HDs over the past fiscal year.
- Demonstrated competency in the use of personal protective equipment (PPE), containment systems, and spill management procedures. (correct answer)
Explanation: USP <800> requires that all personnel who handle HDs are specifically trained and demonstrate competency in areas critical to safety. This includes the proper use of PPE, the function of engineering controls like biological safety cabinets, and the correct procedures for managing and cleaning up HD spills. The other options are either not required or do not address the specific safety competencies of HD handling.
Question 8
A state board of pharmacy inspector arrives at a pharmacy and requests to see documentation proving that all personnel involved in compounding are competent.
Which of the following sets of records would best satisfy the inspector's request for an employee who performs sterile compounding?
- A single logbook signed annually by all employees, attesting that they have completed all required training modules online.
- A personnel file for the employee containing the results of their didactic training, media-fill tests, and gloved fingertip sampling. (correct answer)
- The Master Formulation Records for each compounded product, initialed by the employee to show they are familiar with the formulas.
- A certificate of completion from a national compounding training seminar attended by the employee three years prior.
Explanation: Proper documentation of competency requires maintaining individual records for each person involved in compounding. For sterile compounding, this file must include evidence of both didactic (knowledge-based) training and practical skills assessment, such as the results of media-fill tests and gloved fingertip sampling. The other options lack the required detail and evidence of ongoing, hands-on skills verification.
Question 9
A significant error occurs in a batch of nonsterile compounded capsules, which is traced back to a technician's failure to follow the Standard Operating Procedure (SOP).
According to USP General Chapters on compounding, who holds the ultimate responsibility for the adequacy of the pharmacy's training program and the competency of all personnel involved in compounding?
- The individual technician who made the compounding error.
- The pharmacist who performed the final verification of the compounded batch.
- The pharmacy's designated person(s). (correct answer)
- The state board of pharmacy, through its inspection and oversight functions.
Explanation: USP standards (<795>, <797>, <800>) place the ultimate responsibility for the performance and oversight of all compounding activities on one or more designated persons. This includes ensuring that all personnel are properly trained and competent to perform their assigned duties. While others have roles and responsibilities, the designated person is accountable for the entire system.
Question 10
A pharmacy technician has been compounding hazardous drugs (HDs) for several years. The designated person is planning the annual competency reassessment for all staff handling HDs.
According to USP <800>, the annual reassessment of this technician's competency MUST include which of the following?
- A blood test to screen for any signs of hazardous drug exposure.
- Demonstration of adherence to the proper handling procedures for hazardous drugs. (correct answer)
- The ability to correctly identify at least 90% of the drugs on the current NIOSH list.
- Successful completion of a written examination with a score of at least 95%.
Explanation: USP <800> requires that competency of personnel handling HDs be reassessed at least every 12 months. This assessment must evaluate their adherence to the pharmacy's SOPs, including practical skills like proper use of PPE and engineering controls. While written exams can be part of an assessment, the core requirement is evaluating demonstrated practice. Medical surveillance is a separate consideration, not a competency measure.
Question 11
A 503A pharmacy that performs nonsterile compounding purchases a new ointment mill to improve the quality of its topical preparations.
Before any compounding personnel are permitted to use this new equipment to prepare patient prescriptions, what must occur?
- The manufacturer's training certificate for the equipment must be filed in the pharmacy's administrative records.
- All compounding personnel must retake their initial comprehensive nonsterile compounding competency exam.
- Personnel must be trained on the ointment mill's operation, cleaning, and maintenance, and their specific competency must be documented. (correct answer)
- The pharmacist-in-charge must personally use the equipment to compound three test batches to validate its function.
Explanation: When new equipment is introduced that can affect the quality of a final preparation, personnel must be specifically trained on its use. This training must cover operation, cleaning, and any required calibration or maintenance. The pharmacy must then assess and document each individual's competency with the new device before they are allowed to use it for patient-specific compounding.
Question 12
A pharmacist works at a facility that compounds Category 2 sterile preparations. The facility's SOPs require competency assessments at the minimum frequency mandated by USP standards.
How often must this pharmacist successfully complete gloved fingertip and thumb sampling?
- At least every twelve months, if no growth is detected.
- At least every three months due to the higher risk of Category 2 preparations.
- Only upon initial qualification and again if a media-fill test is failed.
- At least every six months. (correct answer)
Explanation: For personnel compounding Category 1 or Category 2 CSPs, the current USP <797> standard requires gloved fingertip and thumb sampling to be performed at least every six months. This frequency is aligned with the semi-annual requirement for media-fill testing for these personnel.
Question 13
A pharmacy is conducting a media-fill test as part of a technician's competency assessment.
The primary purpose of having the technician perform manipulations with a microbial growth medium, such as tryptic soy broth, during this test is to:
- verify the sterility of the growth medium provided by the manufacturer.
- evaluate the technician's ability to aseptically perform steps that simulate the compounding process. (correct answer)
- determine the correct incubation parameters required for the pharmacy's environmental monitoring program.
- confirm that the technician is able to correctly label a compounded sterile preparation.
Explanation: A media-fill test is a process simulation designed to assess a compounder's aseptic technique. By using a sterile microbial growth medium instead of actual drug products, the test can determine if the compounder introduces microbial contamination during the manipulations that mimic their routine compounding tasks. A lack of turbidity after incubation indicates the technique was aseptic.
Question 14
The designated person at a new pharmacy is developing the initial didactic training curriculum for all personnel who will be involved in sterile compounding.
According to USP <797>, which of the following topics MUST be included in this foundational training program?
- Billing and reimbursement codes for common compounded sterile preparations.
- Principles of aseptic technique and proper garbing procedures. (correct answer)
- Advanced clinical pharmacokinetics for patient-specific dose adjustments.
- State-specific regulations regarding the mail-order dispensing of compounded medications.
Explanation: The core of any sterile compounding training program must be foundational knowledge of aseptic principles. This includes, but is not limited to, proper hand hygiene, garbing procedures, cleanroom behavior, and the fundamental techniques required to prevent microbial contamination of preparations. The other topics are administrative, clinical, or legal in nature and are separate from the core competency of aseptic manipulation.
Question 15
A hospital's central pharmacy receiving technician is responsible for unpacking daily drug shipments from a wholesaler. These shipments often contain hazardous drugs (HDs) that require special handling.
What is the minimum competency requirement for this receiving technician according to USP <800>?
- No specific training is required as they are not involved in the compounding or administration of the HDs.
- The technician must be trained on proper HD handling, use of PPE for unpacking, and spill response, with competency documented. (correct answer)
- The technician must complete the same aseptic manipulation and media-fill testing as sterile compounding personnel.
- The technician must sign a waiver acknowledging the risks of handling HDs, which fulfills the USP training requirement.
Explanation: USP <800> applies to all personnel who handle HDs throughout their lifecycle in the facility, including receipt and unpacking. Therefore, this technician must be trained on the entity's SOPs for handling HDs, which includes understanding the risks, wearing appropriate PPE (e.g., gloves), and knowing what to do in case of a spill or damaged container. This competency must be documented.
Question 16
A pharmacy technician has been performing nonsterile compounding of creams, ointments, and capsules for several years with an excellent record.
According to USP <795>, what is the minimum frequency for the formal reassessment of this technician's compounding competency?
- Every 6 months.
- Every 12 months. (correct answer)
- Every 24 months.
- Only when an error is identified or a new type of formulation is introduced.
Explanation: USP <795> requires that the competency of personnel performing nonsterile compounding be reassessed at least every 12 months. This ensures that their skills and knowledge remain current. While reassessment should also occur if there are changes in procedures or if problems are identified, the annual reassessment is a minimum requirement.
Question 17
A pharmacist who was responsible for supervising the sterile compounding area leaves their position at a hospital. The pharmacy director is reviewing the file retention policy for former employees.
What is the general requirement for retaining the departing pharmacist's competency assessment records (e.g., media-fill and GFS results)?
- The records should be given to the departing pharmacist for their professional portfolio and removed from pharmacy files.
- The records must be maintained by the pharmacy for a specified period (e.g., at least 2 years) after the person ceases compounding. (correct answer)
- The records may be shredded immediately upon the employee's final day of work to protect their privacy.
- The records must be sent to the state board of pharmacy to be archived with the pharmacist's license information.
Explanation: Regulatory bodies and accreditation standards typically require that all compounding-related records, including personnel training and competency assessments, be maintained for a specific period of time even after an employee leaves. This period is often 2-3 years or as defined by state law. This ensures a complete record exists in case of future audits or investigations.
Question 18
A designated person is performing the annual competency reassessment of a technician who performs nonsterile compounding.
In addition to a written or verbal test of knowledge, which of the following is an essential and required component of this reassessment under USP <795>?
- Reviewing the technician's employee attendance record for the past twelve months.
- Having the technician verbally describe the process for compounding a complex suspension from memory.
- Verifying that the technician has read and initialed all updated Standard Operating Procedures (SOPs).
- Direct visual observation of the technician compounding at least one preparation from start to finish. (correct answer)
Explanation: A key component of competency assessment for nonsterile compounding is the direct observation of the compounder's technique and adherence to procedures. A written test or verbal description alone is insufficient to verify practical skills. The designated person must watch the technician perform the compounding process to ensure they are following all critical steps correctly.
Question 19
A pharmacy hires a recent pharmacy school graduate who has studied sterile compounding academically but has no prior work experience in an IV cleanroom.
Before this new pharmacist can independently compound sterile preparations, the pharmacy's training program MUST include which of the following?
- A 40-hour shadowing period with an experienced technician, followed by a final exam.
- Proof of passing the NAPLEX and MPJE licensure examinations within the past year.
- Didactic instruction on compounding principles followed by hands-on skills demonstration and evaluation. (correct answer)
- A review of the top 200 most commonly compounded preparations made by the pharmacy.
Explanation: Initial qualification for sterile compounding requires a comprehensive approach. According to USP <797>, this must include both didactic (theoretical) training on the principles of sterile compounding and a hands-on component where the trainee demonstrates proficiency in required skills (e.g., garbing, aseptic manipulation) under direct observation, which is then formally evaluated.
Question 20
While observing a technician compound a sterile preparation, the supervising pharmacist notices the technician failed to disinfect a vial septum with sterile 70% isopropyl alcohol (IPA) before piercing it with a needle.
What is the most appropriate action for the supervising pharmacist to take based on this breach of aseptic technique?
- Issue a formal written warning for the failure to follow SOPs but allow the technician to finish compounding.
- Wait until the technician's next scheduled semi-annual competency assessment to address the issue comprehensively.
- Intervene immediately, provide corrective retraining on the specific step, and document the event and retraining. (correct answer)
- Discard the single preparation being made and have a different technician re-compound it from the beginning.
Explanation: Breaches in aseptic technique must be addressed immediately to ensure patient safety and correct poor habits. The appropriate response is to stop the process, provide on-the-spot corrective retraining for the specific error, and document the observation and the remedial action taken. This addresses both the immediate risk and the long-term competency of the employee.